Navigation Links
Study Shows GSK's Novel Diabetes Treatment SYNCRIA(R) (albiglutide) Improves Glucose Control and Reduces Weight
Date:6/7/2009

LONDON, RESEARCH TRIANGLE PARK, N.C., and NEW ORLEANS, June 7 /PRNewswire-FirstCall/ -- New Phase II data presented today at the American Diabetes Association 69th Scientific Sessions in New Orleans show that the investigational type 2 diabetes treatment Syncria(R) (albiglutide) significantly reduced blood glucose levels and provided weight loss across weekly, biweekly and monthly dosing. Reducing blood sugar is a key part of managing type 2 diabetes, a disease that affects over 250 million people worldwide.

In the study, dose-dependent reductions in A1C - a measure of how well blood sugar is being controlled over time - with albiglutide 30 mg weekly, 50 mg biweekly, and 100 mg monthly were 0.9%, 0.8% and 0.9% respectively (p<0.05). The A1C reduction by placebo was 0.2% and by open-label exenatide was 0.5%. Weight loss (0.9 to 1.8 kg) was observed across all doses. The most frequently reported adverse events included nausea, vomiting and headache. At the 30 mg weekly dose, fewer than 10% of patients experienced nausea and vomiting, which subsided after week eight. Albiglutide was not shown to increase the risk of abnormally low blood sugar, known as hypoglycemia.

"Despite a range of available diabetes therapies, over half of patients with type 2 diabetes are unable to achieve the ADA target blood sugar goal," said the study's lead investigator, Julio Rosenstock, MD of the Dallas Diabetes and Endocrine Center at Medical City and clinical professor of medicine, University of Texas Southwestern Medical School. "While these results need to be confirmed in ongoing studies, the findings with albiglutide are important since weight gain and fear of increased blood sugar levels can be major barriers to diabetes management."

Study design

The primary objective of the study was to evaluate the dose response of albiglutide for safety and efficacy. The primary efficacy endpoint was cha
'/>"/>

SOURCE GlaxoSmithKline
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 27, 2015 Pharmaceutical and biotech marketers are ... for the same indication. This can be a complex ... prevent one of their brands from gaining market share ... recent research by benchmarking firm, Best Practices, LLC, 75% ... rather than together as part of a franchise. Marketers ...
(Date:2/27/2015)... 2015  Acsis Inc., the market leader for supply ... that John DiPalo , Acsis, Chief Strategy Officer, ... Chain Executive 2015 Provider Pro to Know. The ... to help prepare their companies, and customers, supply chains ... year,s list of Provider Pros to Know is featured ...
(Date:2/27/2015)... HOUSTON, TX , Feb. 27, 2015 /PRNewswire/ - ESSA ... Bloom Burton & Co. Ltd. ("Bloom Burton") today announced ... "Lock-Up") 2,353,130 common shares of the Company ("Common Shares") ... the Lock-Up. Of the Common Shares released from the ... release from the Lock-Up while the remainder will be ...
Breaking Medicine Technology:New Report Details How to Expand a Pharmaceutical Product Portfolio without Cannibalizing an Established Brand 2Acsis CSO John DiPalo Named Supply & Demand Chain Executive 2015 Pro to Know 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 2ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 3ESSA Pharma and Bloom Burton announce additional release of shares from voluntary lock-up agreement 4
... -- Winner Medical Group Inc. (Nasdaq: WWIN ; "Winner ... disposables and non-woven fabric made from 100% natural PurCotton® products in ... March 31, 2011. Second Quarter Fiscal ... increased by 27% over Q2 FY 2010 to $33.2 million ...
... announces that a new market research report is ... for Emerging Pharmaceutical Technologies ... * As a segment, ... figure that is expected to grow to $31.9 ...
Cached Medicine Technology:Winner Medical Reports Second Quarter Fiscal 2011 Results 2Winner Medical Reports Second Quarter Fiscal 2011 Results 3Winner Medical Reports Second Quarter Fiscal 2011 Results 4Winner Medical Reports Second Quarter Fiscal 2011 Results 5Winner Medical Reports Second Quarter Fiscal 2011 Results 6Winner Medical Reports Second Quarter Fiscal 2011 Results 7Winner Medical Reports Second Quarter Fiscal 2011 Results 8Winner Medical Reports Second Quarter Fiscal 2011 Results 9Winner Medical Reports Second Quarter Fiscal 2011 Results 10Winner Medical Reports Second Quarter Fiscal 2011 Results 11Winner Medical Reports Second Quarter Fiscal 2011 Results 12Winner Medical Reports Second Quarter Fiscal 2011 Results 13Winner Medical Reports Second Quarter Fiscal 2011 Results 14Winner Medical Reports Second Quarter Fiscal 2011 Results 15Winner Medical Reports Second Quarter Fiscal 2011 Results 16Winner Medical Reports Second Quarter Fiscal 2011 Results 17Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 2Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 3Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 4Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 5Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 6Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 7Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 8Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 9Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 10Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 11Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 12Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 13Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 14Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 15Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 16Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 17Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 18Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 19Reportlinker Adds Markets for Emerging Pharmaceutical Technologies 20
(Date:2/28/2015)... Vancouver personal injury lawyers at Jiwa Law Corporation recently ... limits. They stated that in many cases, missing an important ... it. Many a time, delays in making an injury claim ... law. As a result, experts at Jiwa Law Corporation suggest ... personal injury lawyer in order to know more about their ...
(Date:2/28/2015)... February 28, 2015 The Mesothelioma ... annual awards at the International Symposium on Malignant Mesothelioma ... held at the Hyatt Regency Bethesda in Bethesda, Maryland. ... dedicated work and commitment to the mission to cure ... Award will be presented to Miriam Ratner. Miriam runs ...
(Date:2/28/2015)... 2015 India Network Foundation, ... health insurance programs for visitors coming to the United ... parents traveling to the United States are suffering from ... blood pressure. These diseases are so common among the ... as medical conditions. There were 66.8 million cases of ...
(Date:2/28/2015)... On Thursday, February 26th, Forbes published an article titled ... Steal Your Data , which stresses the ease with which ... phishing kit, or any kind of malware kit for that ... about how everyone’s cyber security is intertwined when it covers ... content management systems or blogs in order to install the ...
(Date:2/28/2015)... February 28, 2015 Javon Bea ... Mercy Harvard Hospital as stroke capable by the State ... via ambulance to Mercy Harvard Hospital. , The hospital ... indicate their ability to treat stroke according to national ... ambulances transporting stroke patients to bypass hospitals not designated ...
Breaking Medicine News(10 mins):Health News:Jiwa Law Corporation Recently Announced That Time Delays May Weaken Personal Injury Claims 2Health News:Cancer Research Foundation Honors Award Recipients 2Health News:Cancer Research Foundation Honors Award Recipients 3Health News:Cancer Research Foundation Honors Award Recipients 4Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 2Health News:India Network Announces Pre-existing Condition Health Insurance Coverage for Diabetic Visitors of All Ages Traveling to the United States 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 2Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 3Health News:DIY Phishing and Malware Kits Make it Easy to Compromise Businesses in More Ways than One 4Health News:Mercy Harvard Hospital Recognized as Leader in Stroke Care - Javon Bea 2
... ... , ... 2009 -- FCI-BURNDY® Products Renewable Energy Products , including products ideal for use ... included the BURNDYWeld® exothermic Grounding option, the HYGROUND® irreversible compression Grounding system, ...
... ... despite the turbulent economic conditions affecting other real estate development companies. Trilogy Health Systems ... million in value. , ... Cicero, Ind. (PRWEB) June 3, 2009 -- Commercial construction and development are not ...
... Corn Syrup from Baked Goods Not Such A Grande Idea , ... remove high fructose corn syrup from its baked goods later this ... June 2) may be misleading to consumers by implying that products ... , "Consumers could be in for a jolt when they realize ...
... ... access assessment products and other services. , ... San Jose, Calif. (PRWEB) June 3, 2009 -- The Glowan ... opening of a new on-line store allowing clients and partners to purchase their suite ...
... ... More Distributors in Pennsylvania. LeadConfirm Professional, the first and only non-invasive and oral-based lead ... care professionals in Kansas through a wider distribution base. , ... San Diego, CA (Vocus) June 3, 2009 ...
... A simple magnetic resonance imaging (MRI) test involving breathing oxygen ... patients, report researchers at UT Southwestern Medical Center. ... in a tumor can be a predictor of how well ... tend to grow stronger and resist both radiotherapy and chemotherapy. ...
Cached Medicine News:Health News:FCI-BURNDY Products Wins "Best Of Trade Show" Award at Windpower 2009 Conference and Exhibition 2Health News:FCI-BURNDY Products Wins "Best Of Trade Show" Award at Windpower 2009 Conference and Exhibition 3Health News:Wall Street Not Affecting Mainstreet Property Group; Group Breaks Ground on Another Senior Care Campus in Lafayette, IN 2Health News:Wall Street Not Affecting Mainstreet Property Group; Group Breaks Ground on Another Senior Care Campus in Lafayette, IN 3Health News:Wall Street Not Affecting Mainstreet Property Group; Group Breaks Ground on Another Senior Care Campus in Lafayette, IN 4Health News:Wake Up & Smell the Coffee 2Health News:Wake Up & Smell the Coffee 3Health News:Glowan Consulting Announces New On-Line E-Commerce Site 2Health News:Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 2Health News:Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 3Health News:Parents In Kansas Can Now Test Their Children For Lead Exposure Using Saliva 4Health News:Oxygen + MRI might help determine cancer therapy success, researchers find 2
... device is a qualitative immunoassay ... inspect the,overdose usage of cocaine ... metabolite of,cocaine, in human urine ... 300 ng/mL. It is for ...
... is a fully automated, user-friendly system ... labor resources and improve patient care. ... and immunoturbidimetric testing capabilities with a ... assays. It's also a powerful, intuitive ...
... with recombinant technology, that have been fully prove ... detecting the different types of T.cruzi that exist ... acid sequences repeated in tandem. SAPA (shed acute ... the infection, it reacts with 93% of the ...
Inquire...
Medicine Products: